Elinor Aspegren and Adrianna Rodriguez, USA TODAY
The U.S. has vaccinated more than 30% of its population against COVID-19, with more than 101.8 million Americans receiving at least one dose of the vaccine, according to the Centers for Disease Control and Prevention vaccine tracker. More than 17% of the total population has been fully vaccinated, as have more than 53% of those 65 and older.
Meanwhile, Johnson & Johnson has begun vaccinating participants between 12 and 17 years old in its ongoing clinical trial for its COVID-19 vaccine, according to a company statement Friday.
“The COVID-19 pandemic has had a profound impact on adolescents, not just with the complications of the disease, but with their education mental health, and wellbeing,” said Dr. Paul Stoffels, chief scientific officer at Johnson & Johnson. “It is vital that we develop vaccines for everyone, everywhere, to help combat the spread of the virus with the goal to return to everyday life.”
The news follows the release of a Pfizer study that found its COVID-19 vaccine with German partner BioNTech was proven safe and effective for kids ages 12 to 15. The company also announced beginning trials in children under 12 years old.
Read the rest of the story on Yahoo News